| Identification | Back Directory | [Name]
L-Prolinamide, N-(8-carboxy-1-oxooctyl)-3-methyl-L-valyl-4-hydroxy-N-[[4-(4-methyl-5-thiazolyl)phenyl]methyl]-, (4R)- | [CAS]
2172819-76-8 | [Synonyms]
VH032-C6-COOH
VH 032 amide-alkylC7-acid
L-Prolinamide, N-(8-carboxy-1-oxooctyl)-3-methyl-L-valyl-4-hydroxy-N-[[4-(4-methyl-5-thiazolyl)phenyl]methyl]-, (4R)-
9-(((S)-1-((2S,4R)-4-Hydroxy-2-((4-(4-methylthiazol-5-yl)benzyl)carbamoyl)pyrrolidin-1-yl)-3,3-dimethyl-1-oxobutan-2-yl)amino)-9-oxononanoic acid | [Molecular Formula]
C31H44N4O6S | [MOL File]
2172819-76-8.mol | [Molecular Weight]
600.77 |
| Chemical Properties | Back Directory | [Boiling point ]
888.3±65.0 °C(Predicted) | [density ]
1.229±0.06 g/cm3(Predicted) | [solubility ]
DMSO: Soluble: =10 mg/ml
Ethanol: Sparingly soluble: 1-10 mg/mlPBS (pH 7.2): Slightly soluble: 0.1-1 mg/ml | [form ]
Solid | [pka]
4.77±0.10(Predicted) | [color ]
White to off-white |
| Hazard Information | Back Directory | [Uses]
(S,R,S)-AHPC-amido-C7-acid incorporates a VHL ligand for the E3 ubiquitin ligase and a PROTAC linker. (S,R,S)-AHPC-amido-C5-acid can be used to design PROTACs[1]. | [References]
[1] Sun N, et al. Discovery of the First Lactate Dehydrogenase Proteolysis Targeting Chimera Degrader for the Treatment of Pancreatic Cancer. J Med Chem. 2023 Jan 12;66(1):596-610. DOI:10.1021/acs.jmedchem.2c01505 |
|
|